CHA<sub>2</sub>DS<sub>2</sub>‐VASc impact on risk following percutaneous coronary intervention in atrial fibrillation — Thomas Jensen (2021) | RDL Network
CHA<sub>2</sub>DS<sub>2</sub>‐VASc impact on risk following percutaneous coronary intervention in atrial fibrillation
Article 2021 en
Authors
TJ
Thomas Jensen
PT
Pernille Gro Thrane
KO
Kevin Kris Warnakula Olesen
Abstract
1 min read
Implementation of the CHA<sub>2</sub> DS<sub>2</sub> -VASc score in the 2010 European guidelines on AF was associated with an increased utilization of oral anticoagulation and triple therapy among AF patients undergoing PCI. These changes were associated with a gradual decline in the risk of MACE, while the risk of hospitalized bleeding remained unchanged.
Moonki Jung, Kyeongmin Byeon, Ki‐Woon Kang, Yae Min Park, You Mi Hwang, Sung Ho Lee, Eun‐Sun Jin, Seung‐Young Roh, Jin Seok Kim, Jinhee Ahn, So-Ryoung Lee, Eue-Keun Choi, Min‐Soo Ahn, Eun Mi Lee, Hwan-Cheol Park, Ki Hong Lee, Min Kim, Joon‐Hyouk Choi, Jum Suk Ko, Jin‐Bae Kim, Changsoo Kim, Professor Gregory Lip, Seung Yong Shin
Discussion(0)
No comments yet. Be the first to comment.